Newspatrolling.com News cum Content Syndication Portal Online
Thiruvananthapuram, Kerala – February 18, 2025 – The Government of Kerala, in collaboration with Remidio, a leader in AI-driven ophthalmic screening solutions, has launched Nayanamritham 2.0, the world’s first government led AI-assisted chronic eye disease screening program. This pioneering initiative leverages artificial intelligence to enhance early detection and streamline eye disease screening, making quality eye care more accessible and efficient across the state.
Revolutionizing Eye Care with AI
Building on the success of Nayanamritham 1.0, which introduced diabetic retinopathy
(DR) screening at Family Health Centers with expert interpretation by ophthalmologists at secondary and tertiary centers, Nayanamritham 2.0 takes a major leap forward. The new phase empowers optometrists with Remidio’s AI-enabled fundus cameras that instantly classify cases as referable or non-referable, ensuring faster diagnosis and timely referrals.
Building on the success of Nayanamritham 1.0, which introduced diabetic retinopathy
(DR) screening at Family Health Centers with expert interpretation by ophthalmologists at secondary and tertiary centers, Nayanamritham 2.0 takes a major leap forward. The new phase empowers optometrists with Remidio’s AI-enabled fundus cameras that instantly classify cases as referable or non-referable, ensuring faster diagnosis and timely referrals.
In addition to DR, Nayanamritham 2.0 expands its scope to include screening for two major chronic eye diseases – Glaucoma and Age-related Macular Degeneration (AMD). The program now extends across Community Health Centers, Taluk Hospitals, and
District Hospitals, making comprehensive eye care available at all levels of the
healthcare system.
Leadership Perspectives
Anand Sivaraman, CEO of Remidio, highlighted the transformative impact of this
collaboration, stating:
“The Kerala Government has been a pioneer in integrating technology into public
health. With Nayanamritham 2.0, Kerala becomes the first government public health
system in the world to adopt AI for chronic eye disease screening. By integrating
Remidio’s 3-in-1 AI into existing workflows, we are making eye screenings more efficient, accessible, and affordable. This initiative showcases the transformative power of collaboration between the government and Indian health technology innovators all driven by a shared goal: improving lives.”
Anand Sivaraman, CEO of Remidio, highlighted the transformative impact of this
collaboration, stating:
“The Kerala Government has been a pioneer in integrating technology into public
health. With Nayanamritham 2.0, Kerala becomes the first government public health
system in the world to adopt AI for chronic eye disease screening. By integrating
Remidio’s 3-in-1 AI into existing workflows, we are making eye screenings more efficient, accessible, and affordable. This initiative showcases the transformative power of collaboration between the government and Indian health technology innovators all driven by a shared goal: improving lives.”
At the launch event, Dr. Bipin Gopal, Deputy Director, DHS, Government of Kerala, emphasized the role of AI in strengthening healthcare delivery:
“AI isn’t here to replace healthcare providers—it’s here to empower them. By leveraging ethical AI, we are enabling optometrists to detect routine cases with AI-powered cameras, while ophthalmologists can focus on advanced cases, delivering the highest quality care where it’s needed most.“
“AI isn’t here to replace healthcare providers—it’s here to empower them. By leveraging ethical AI, we are enabling optometrists to detect routine cases with AI-powered cameras, while ophthalmologists can focus on advanced cases, delivering the highest quality care where it’s needed most.“
With Nayanamritham 2.0, Kerala is setting a global precedent for seamlessly integrating ophthalmic AI into clinical workflows, making screening programs more efficient, scalable, and cost-effective.
A New Era in AI-Driven Public Health
As AI continues to redefine healthcare globally, Nayanamritham 2.0 represents a
groundbreaking step in harnessing AI for public health in India. This initiative not only
enhances efficiency and accuracy in screenings but also empowers healthcare
providers to deliver better patient care.
As AI continues to redefine healthcare globally, Nayanamritham 2.0 represents a
groundbreaking step in harnessing AI for public health in India. This initiative not only
enhances efficiency and accuracy in screenings but also empowers healthcare
providers to deliver better patient care.
By collaborating with Kerala’s health department, Remidio, a homegrown health
technology company, is pioneering a scalable, data-driven approach to eye care—
driving early detection, reducing preventable blindness, and improving patient outcomes across the state.
technology company, is pioneering a scalable, data-driven approach to eye care—
driving early detection, reducing preventable blindness, and improving patient outcomes across the state.
